Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Antibody immunosuppressive therapy in solid-organ transplant: Part I Mahmud N; Klipa D; Ahsan NMAbs 2010[Mar]; 2 (2): 148-56Currently, a wide variety of both polyclonal and monoclonal antibodies are being routinely utilized to prevent and treat solid organ rejection. More commonly, these agents are also administered in order to delay introduction of calcineurin inhibitors, especially in patients with already compromised renal function. While these antibody therapies dramatically reduced the incidence of acute rejection episodes and improved both short and long-term graft survival, they are also associated with an increased incidence of opportunistic infections and neoplastic complications. Therefore, effective patient management must necessarily balance these risks against the potential benefits of the therapy.|*Immunosuppression Therapy[MESH]|*Immunotherapy[MESH]|*Organ Transplantation[MESH]|Animals[MESH]|Antibodies, Monoclonal/adverse effects/*therapeutic use[MESH]|Graft Rejection/*drug therapy/immunology[MESH]|Humans[MESH]|Monitoring, Physiologic[MESH]|Neoplasms/etiology/prevention & control[MESH]|Opportunistic Infections/etiology/prevention & control[MESH] |
